Skip to content
Screener

Passage Bio, Inc. PASG Q1 2026 earnings

Reported May 12, 2026 · Before market open

EPS-$2.36Miss by $0.21
EPS estimate-$2.15

Next report

Nov 9, 2026 (in 2 months)
EPS estimate-$2.44

FAQ

When did Passage Bio, Inc. report Q1 2026 earnings?
Passage Bio, Inc. (PASG) reported Q1 2026 earnings on May 12, 2026 before market open.
What were Passage Bio, Inc.'s Q1 2026 revenue and EPS?
Passage Bio, Inc. reported eps of $-2.36 for Q1 2026.
Did Passage Bio, Inc. beat estimates in Q1 2026?
EPS missed the consensus estimate of $-2.15 by $0.21.
How did Passage Bio, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 52.8% from $-5.00.
Where can I find Passage Bio, Inc.'s Q1 2026 SEC filings?
You can read the 10-Q periodic report (0001104659-26-058987) directly on SEC EDGAR. The filing index links above go to sec.gov.